Valuation: CEREP

Market Cap 82.22M 94.9M 76.61M 70.35M 133M 9.06B 135M 902M 354M 4.51B 356M 349M 14.95B P/E 2024 *
-
P/E 2025 -
Enterprise Value 61.18M 70.62M 57.01M 52.35M 98.97M 6.74B 100M 671M 263M 3.36B 265M 259M 11.12B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/04/2024
Director TitleAgeSince
Director/Board Member - -
Chairman - 11/08/2023
Director/Board Member - 23/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%+2.59%-1.71%+11.28% 48.53B
-2.41%-0.90%+411.96%+495.33% 39.87B
-1.16%+12.96%+28.81%+7.25% 38.68B
-1.88%-3.03%+5.69%+53.00% 35.13B
-1.74%+5.12%+14.44%+41.77% 29.79B
-0.21%-4.04%+36.40%+125.75% 16.11B
-2.85%-3.92% - - 16.08B
-0.64%+2.65%+3.40%+13.11% 13.61B
-1.19%-1.32%-1.73%-34.37% 12.62B
Average -1.50%+1.05%+62.16%+89.14% 27.82B
Weighted average by Cap. -1.60%+2.03%+79.78%+108.61%

Financials

2024 2025
Net sales 40.49M 46.74M 37.72M 34.65M 65.49M 4.46B 66.36M 444M 174M 2.22B 176M 172M 7.36B 41.1M 47.44M 38.29M 35.17M 66.48M 4.53B 67.36M 451M 177M 2.26B 178M 174M 7.47B
Net income 7.15M 8.26M 6.67M 6.12M 11.57M 788M 11.73M 78.52M 30.79M 393M 31.02M 30.34M 1.3B 4.78M 5.52M 4.46M 4.09M 7.74M 527M 7.84M 52.48M 20.58M 262M 20.73M 20.28M 869M
Net Debt -17.25M -19.92M -16.08M -14.76M -27.91M -1.9B -28.28M -189M -74.26M -947M -74.8M -73.16M -3.14B -21.03M -24.28M -19.6M -18M -34.03M -2.32B -34.47M -231M -90.54M -1.15B -91.19M -89.2M -3.82B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-